NEW YORK (GenomeWeb News) – A team of American and German researchers has used a systems biology approach to integrate various genomic and clinical features of brain cancer. In the process, the team found a set of non-random mutations that often co-exist in cancer — and pulled out a handful of genes in the brain cancer network that were linked to patient survival.

The group's research appears in a pair of papers in today's issue of the Journal of the American Medical Association.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.